Veritas Investment Management Llp Holds Position in Thermo Fisher Scientific INC (TMO)

Gladys Abbott
June 14, 2017

Therefore 43% are positive. Morgan Stanley boosted their price objective on Thermo Fisher Scientific from $186.00 to $192.00 and gave the stock an "overweight" rating in a research report on Friday, April 28th. (NYSE:TMO) or 4,688 shares. RI decreased its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 2.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. (NYSE:TMO) rating on Thursday, July 23. On Tuesday, May 3 the stock rating was maintained by Mizuho with "Buy". Argus Research initiated the stock with "Buy" rating in Tuesday, October 6 report. Finally, Leerink Swann set a $187.00 price objective on Thermo Fisher Scientific and gave the stock a "buy" rating in a research note on Thursday, April 27th. Jefferies has "Hold" rating and $160 target. See Thermo Fisher Scientific Inc. Wealthsource Partners LLC purchased a new stake in shares of Thermo Fisher Scientific during the third quarter valued at about $516,000. Chevy Chase Trust Holdings Inc. now owns 338,114 shares of the medical research company's stock valued at $51,935,000 after buying an additional 5,944 shares during the last quarter. Advisor Partners LLC now owns 7,371 shares of the medical research company's stock valued at $1,172,000 after buying an additional 1,209 shares in the last quarter. Enersys now has $3.37 billion valuation. The stock increased 1.54% or $1.01 during the last trading session, reaching $66.57. Following the completion of the sale, the chief executive officer now owns 269,279 shares of the company's stock, valued at approximately $46,528,718.41.

Thermo Fisher Scientific (NYSE:TMO) last announced its earnings results on Wednesday, April 26th. It has underperformed by 9.21% the S&P500.

In other Thermo Fisher Scientific news, VP Peter M. Wilver sold 9,079 shares of the stock in a transaction that occurred on Wednesday, March 15th. The insider Jones Myles sold 263 shares worth $21,889.

More news: AG Rosenstein sees no reason to fire Mueller

Investors sentiment increased to 1.05 in Q4 2016. Its up 0.26, from 0.79 in 2016Q3. It improved, as 49 investors sold LMT shares while 363 reduced holdings. Fil, a Bermuda-based fund reported 45,758 shares. Assetmark reported 0% of its portfolio in EnerSys (NYSE:ENS). 94,516 were reported by Northeast Inv Mngmt. United Kingdom-based Waverton Inv Management has invested 4.8% in Lockheed Martin Corporation (NYSE:LMT). (NYSE:TMO). Raymond James Na invested in 0.13% or 11,167 shares. Sadoff Investment Mgmt Limited Liability Company reported 3,050 shares stake. Chesapeake Asset Management Ltd Liability Com invested in 22,515 shares. New York-based Catalyst Capital Advsrs Limited Liability Com has invested 0.04% in Metlife Inc (NYSE:MET). Farmers Company reported 2,799 shares. Institutional investors and hedge funds own 86.89% of the company's stock. Prospector Prtn Limited Co stated it has 0.16% in Metlife Inc (NYSE:MET). (TMO) stock showed the move of -0.89% with the closing price of $173.38. Thermo Fisher Scientific had a net margin of 11.58% and a return on equity of 15.73%. The company's quarterly revenue was up 10.9% compared to the same quarter previous year. TMO's profit will be $872.46 million for 19.26 P/E if the $2.25 EPS becomes a reality. (NYSE:TMO) has "Hold" rating given on Friday, April 29 by Jefferies. Therefore 63% are positive. Thermo Fisher Scientific's dividend payout ratio is presently 10.95%. Tudor Pickering downgraded HollyFrontier Corp (NYSE:HFC) on Monday, February 27 to "Sell" rating. Scotia Capital has "Sector Perform" rating and $59 target. (NYSE:TMO) rating on Tuesday, July 19. The rating was upgraded by RBC Capital Markets on Wednesday, January 6 to "Outperform". BTIG Research has "Buy" rating and $180 target. The stock of Lockheed Martin Corporation (NYSE:LMT) has "Buy" rating given on Thursday, August 20 by Sterne Agee CRT. The stock has "Buy" rating by Stifel Nicolaus on Friday, May 6. Hm Payson & owns 5,709 shares or 0.01% of their USA portfolio. Abiomed Inc (NASDAQ:ABMD) was raised too. About 555,313 shares traded. $396,775 worth of Thermo Fisher Scientific Inc. It has underperformed by 1.13% the S&P500. (NYSE:TMO) news were published by: which released: "Thermo Fisher Scientific Declares Quarterly Dividend" on May 18, 2017, also with their article: "Thermo Fisher Scientific Raises the Bar in Mass Spectrometry Innovation at ..." published on June 05, 2017, published: "Thermo Fisher Scientific Introduces Latest in Capillary Electrophoresis ..." on May 22, 2017. The company has market cap of $. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Investors sentiment decreased to 1.03 in Q4 2016. Its down 0.05, from 0.98 in 2016Q3. Analysts anticipate that Thermo Fisher Scientific Inc will post $9.22 EPS for the current year. 116 funds opened positions while 329 raised stakes. The medical research company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $2.02 by $0.06. Fred Alger Management holds 0.28% or 361,758 shares. (NYSE:TMO) on Friday, March 10. 3,142 Thermo Fisher Scientific Inc. Reinhart invested in 0.04% or 2,850 shares. (NYSE:TMO) or 3,142 shares. Wilbanks Smith And Thomas Asset Ltd Co reported 5,655 shares. Bank of America downgraded the shares of KEP in report on Monday, March 7 to "Underperform" rating. (NYSE:TMO) have been seen trading 12.44% away from the 200-day moving average and 4.84% off the 50-day moving average.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. OLD National Bancorp IN's holdings in Thermo Fisher Scientific were worth $15,116,000 at the end of the most recent reporting period. (NYSE:TMO). Buffington Mohr Mcneal has 0.48% invested in Thermo Fisher Scientific Inc.

Other reports by LeisureTravelAid

Discuss This Article